Targeting the α₉α₁₀ nicotinic acetylcholine receptor to treat severe pain

Author： Vincler Michelle McIntosh J Michael

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.7, 2007-07, pp. : 891-897

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of a Novel O-Conotoxin Reveals an Unusual and Potent Inhibitor of the Human α9α10 Nicotinic Acetylcholine Receptor

By Jiang Shantong Tae Han-Shen Xu Shaoqiong Shao Xiaoxia Adams David J. Wang Chunguang

Marine Drugs, Vol. 15, Iss. 6, 2017-06 ,pp. : 170-170

MDPI

Access to resources Recommend Favorite

Stress and the α7 Nicotinic Acetylcholine Receptor

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 607-612

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting 7 Nicotinic Acetylcholine Receptors in the Treatment of Schizophrenia

Current Pharmaceutical Design, Vol. 16, Iss. 5, 2010-02 ,pp. : 538-554

Bentham Science Publishers

Access to resources Recommend Favorite

Role of α7-Nicotinic Acetylcholine Receptor in Normal and Cancer Stem Cells

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 356-365

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 623-630

Bentham Science Publishers

Access to resources Recommend Favorite